http://www.hepatitisfoundation.org.nz/blog/ The latest Blog feeds from www.hepatitisfoundation.org.nz en-us Thu, 23 Apr 2026 20:07:36 +1200 Rocketspark http://www.hepatitisfoundation.org.nz/blog/post/163083/liver-cirrhosis-market-research/ A market research project is being conducted to understand the experiences of adults living with liver cirrhosis or Hepatitis B.Anyone aged 18 years of age or over who has been diagnosed with liver cirrhosis or Hepatitis B is eligible to participate.Participation in the project would involve completing a 15 to 20-minute online survey. In appreciation of your time and effort, $50 will be provided for completing the survey.The project has been commissioned by a pharmaceutical manufacturer, and is ... Wed, 01 Apr 2026 17:52:01 +1300 http://www.hepatitisfoundation.org.nz/blog/#post163083 http://www.hepatitisfoundation.org.nz/blog/post/159784/journal-of-gastroenterology-and-hepatology/ Hepatitis Delta in Aotearoa/New Zealand Nicola Caine 1, 2 , Lynnaire Matthews 1 , Amanda Broxholme 11 Hepatitis Foundation New Zealand, Tauranga, New Zealand, 2 Hepatology Nurse Practitioner, Tauranga, New ZealandIntroduction: Global hepatitis delta (HDV) epidemiology is limited, especially in the Pacific region. International guidelines vary but are increasingly aligning with WHO's recommendation to screen all those living with chronic hepatitis B (HBV)for HDV. Aotearoa lacks national HDV scree... Tue, 03 Feb 2026 09:40:55 +1300 http://www.hepatitisfoundation.org.nz/blog/#post159784 http://www.hepatitisfoundation.org.nz/blog/post/153427/critical-importance-of-hepatitis-b-vaccine/ Following the Centers for Disease Control and Prevention's vaccine recommendation narrowing the agency's hepatitis B immunisation guidance for newborns in the United States the Hepatitis Foundation of New Zealand today reaffirmed its unwavering support for the country’s universal hepatitis B vaccination schedule which has been a cornerstone of New Zealand's public health for over 35 years.In 1989, following a world-first study into the efficacy of hepatitis B vaccine for children, led by the F... Thu, 11 Dec 2025 00:00:00 +1300 http://www.hepatitisfoundation.org.nz/blog/#post153427 http://www.hepatitisfoundation.org.nz/blog/post/158000/healthy-livers/ We recently held a Webinar hosted by My Health Hub on Healthy Livers, the replay is now available.The Webinar was hosted by Dr Alex Lampen- Smith Specialist in Gastroenterology/Hepatology and Medical Director for the Hepatitis Foundation of NZ.Over 400 New Zealanders are diagnosed with primary liver cancer (hepatocellular carcinoma, HCC), each year. This cancer disproportionately impacts Maori, Pasifika, and Asian communities as hepatitis B is the main cause. 94,000 people in Aotearoa ... Wed, 15 Oct 2025 00:00:00 +1300 http://www.hepatitisfoundation.org.nz/blog/#post158000 http://www.hepatitisfoundation.org.nz/blog/post/152516/webinar-healthy-livers-understanding-the-causes-and-how-to-reduce-the-risk-of-liver-cancer/ Come along to our Webinar on October 8th - Healthy livers: Understanding the causes and how to reduce the risk of liver cancer.Over 400 New Zealanders are diagnosed with primary liver cancer (hepatocellular carcinoma, HCC), each year. This cancer disproportionately impacts Maori, Pasifika, and Asian communities, as hepatitis B is the main cause. 94,000 people in Aotearoa are living with hepatitis B (HBV), and almost half are undiagnosed. Along with hepatitis B, metabolic-associated steatotic liv... Fri, 19 Sep 2025 17:07:13 +1200 http://www.hepatitisfoundation.org.nz/blog/#post152516 http://www.hepatitisfoundation.org.nz/blog/post/149688/webinar-a-to-t-of-hbv/ We recently held a Webinar hosted by My Health Hub on the A to T of HBV, the replay is now available.The Webinar was hosted by Dr Alex Lampen- Smith Specialist in Gastroenterology/Hepatology and Medical Director for the Hepatitis Foundation of NZWith chronic hepatitis B the leading cause of liver cancer in New Zealand the Hepatitis Foundation, in alignment with International Guidelines and the World Health Organisation, is recommending increased treatment uptake. To enable our rural patient... Wed, 30 Jul 2025 09:33:17 +1200 http://www.hepatitisfoundation.org.nz/blog/#post149688 http://www.hepatitisfoundation.org.nz/blog/post/151009/contact-chronic-hepatitis-b-in-aotearoa/ Despite decades of vaccine availability, chronic hepatitis B (CHB) remains a major global health challenge. The World Health Organization’s (WHO) 2024 Global Hepatitis Report estimates around 254 million people were living with CHB in 2022, with 1.2 million new infections each year.  CHB can lead to persistent liver inflammation, increasing the risk of cirrhosis and hepatocellular carcinoma (HCC) – the most common form of primary liver cancer. Globally, viral hepatitis is a leading cau... Tue, 29 Jul 2025 00:00:00 +1200 http://www.hepatitisfoundation.org.nz/blog/#post151009 http://www.hepatitisfoundation.org.nz/blog/post/149362/the-hepatitis-foundation-and-gsk-join-forces/ The Hepatitis Foundation of New Zealand (HFNZ) and GSK New Zealand Limited (GSK) today announced the signing of a Memorandum of Understanding (MOU), formalising a collaborative commitment to eliminate hepatitis B in Aotearoa, New Zealand. This strategic partnership unites the expertise and resources of both organisations to improve health outcomes for New Zealanders affected by chronic hepatitis B (CHB).This announcement comes ahead of World Hepatitis Day on July 28th, an annual global event th... Thu, 24 Jul 2025 13:12:56 +1200 http://www.hepatitisfoundation.org.nz/blog/#post149362 http://www.hepatitisfoundation.org.nz/blog/post/143661/goodfellow-conference-2025/ This past weekend our community nurses participated with a stand in the Good Fellow Symposium 2025, a key event for healthcare professionals in primary and secondary care. Our team engaged in meaningful discussions with doctors, nurse practitioners, and registered nurses, focusing on enhancing Hepatitis B monitoring, management and treatment practices.The symposium provided a valuable platform for us to:Share the latest resources and guidelines on Hepatitis B screening, patient management, and m... Fri, 28 Mar 2025 00:00:00 +1300 http://www.hepatitisfoundation.org.nz/blog/#post143661 http://www.hepatitisfoundation.org.nz/blog/post/142521/liver-cancer-drugs-receive-pharmac-funding/ We are so pleased to announce that liver cancer drugs Tecentriq and Bevacizumab will receive Pharmac funding! 🎗️ Tecentriq in combination with bevacizumab will help the 70 or so New Zealanders diagnosed with Hepatocellular Carcinoma (HCC) each year.This is a huge step forward for liver cancer patients and their families in Aotearoa, providing access to standard-of-care treatment.Dr. Kerryn Symons, Country Medical Director at Roche New Zealand, explains: "Atezolizumab is an immunotherap... Mon, 03 Mar 2025 14:29:27 +1300 http://www.hepatitisfoundation.org.nz/blog/#post142521